rate 16  General:  Obese, NAD CV:  RRR LUNGS:  Rhonchi  Physical examination:  [**2139-2-5**]  Pertinent Results: [**2139-4-6**] 09:05AM BLOOD WBC-7.6 RBC-3.11* Hgb-9.2* Hct-28.7* MCV-93 MCH-29.5 MCHC-31.9 RDW-15.0 Plt Ct-505* [**2139-4-5**] 06:00AM BLOOD WBC-6.2 RBC-2.95* Hgb-9.0* Hct-27.3* MCV-92 MCH-30.4 MCHC-32.9 RDW-15.2 Plt Ct-507* [**2139-4-4**] 05:45AM BLOOD WBC-6.4 RBC-2.52* Hgb-7.8* Hct-23.5* MCV-93 MCH-30.8 MCHC-33.0 RDW-15.2 Plt Ct-397 [**2139-4-3**] 05:50AM BLOOD WBC-7.1 RBC-2.62* Hgb-8.0* Hct-24.0* MCV-92 MCH-30.4 MCHC-33.1 RDW-14.9 Plt Ct-429 [**2139-3-27**] 03:35PM BLOOD Neuts-70.1* Lymphs-23.1 Monos-3.7 Eos-2.6 Baso-0.5 [**2139-4-6**] 09:05AM BLOOD Plt Ct-505* [**2139-4-5**] 06:00AM BLOOD Plt Ct-507* [**2139-4-4**] 05:45AM BLOOD Plt Ct-397 [**2139-3-27**] 03:35PM BLOOD PT-13.2 PTT-22.1 INR(PT)-1.1 [**2139-4-8**] 05:10AM BLOOD UreaN-8 Creat-1.0 Na-134 K-3.8 Cl-104 [**2139-4-7**] 11:10AM BLOOD Na-140 K-5.2* Cl-107 [**2139-4-6**] 09:05AM BLOOD Glucose-112* UreaN-10 Creat-1.0 Na-138 K-5.2* Cl-105 HCO3-26 AnGap-12 [**2139-4-4**] 05:45AM BLOOD Glucose-99 UreaN-16 Creat-1.2 Na-142 K-3.7 Cl-105 HCO3-31 AnGap-10 [**2139-3-31**] 02:33AM BLOOD ALT-16 AST-32 AlkPhos-109 TotBili-0.5 [**2139-3-30**] 12:15PM BLOOD ALT-20 AST-33 AlkPhos-119 TotBili-0.4 [**2139-3-29**] 09:35PM BLOOD CK(CPK)-272 [**2139-3-30**] 12:50AM BLOOD CK-MB-3 cTropnT-0.02* [**2139-3-29**] 09:35PM BLOOD CK-MB-3 cTropnT-0.04* [**2139-4-6**] 09:05AM BLOOD Calcium-9.1 Phos-2.6* Mg-1.9  [**2139-3-27**]:  EKG:  Sinus rhythm and frequent atrial ectopy.
Compared to the previous tracing of [**2139-1-8**] no diagnostic interim change.
[**2139-3-30**]:  Chest x-ray:  FINDINGS: In comparison with the study of [**3-29**], there are lower lung volumes.
Enlargement of the cardiac silhouette with pulmonary vascular congestion and probable bilateral pleural effusions are again seen.
The pulmonary artery systolic pressure could not be determined.
IMPRESSION: Sub-optimal study but [**Hospital1 **]-ventricular systolic function appear to be normal with no evidence of valvular pathology.
[**2139-4-2**]:  Chest x-ray:   Portable AP chest radiograph was reviewed in comparison to [**2139-4-1**] radiographs.
The feeding tube tip is not included in the field of view but on the prior study demonstrated it to be in the stomach.
Compared to the previous tracing of [**2139-4-4**] the underlying artifact has improved  [**2139-3-31**] 4:31 pm SPUTUM      Source: Induced.
RESPIRATORY CULTURE (Final [**2139-4-2**]):       SPARSE GROWTH Commensal Respiratory Flora.
SENSITIVITIES PERFORMED ON CULTURE # 316-4888H ON [**2139-3-30**]    [**2139-3-30**] 11:34 am MRSA SCREEN      Source: Nasal swab.
**FINAL REPORT [**2139-3-31**]**     MRSA SCREEN (Final [**2139-3-31**]):       POSITIVE FOR METHICILLIN RESISTANT STAPH AUREUS  GENERAL URINE INFORMATION Type Color Appear Sp [**Last Name (un) **] [**2139-3-27**] 14:47      Yellow Clear 1.016 Source: Kidney DIPSTICK URINALYSIS Blood Nitrite Protein Glucose Ketone Bilirub Urobiln pH Leuks [**2139-3-27**] 14:47    NEG NEG NEG NEG NEG NEG NEG 5.0 NEG Source: Kidney  [**2139-3-30**] 12:13 pm BLOOD CULTURE      Source: Line-right subclavian.
On POD #6, he was transferred to the floor.
His vital signs are stable and he is afebrile  He continues on his ciprofloxacin for pneumonia and required encouragement to cough.
Medications on Admission: Lisinopril 20', Loratatidine 10', Diltiazem 120''', Trazadone 50 QHS, Zoloft 50', Lantus 20 QHS, senna 8.6 2 tabs QHS, bisacodyl 10 suppository PRN', Milk of Mag PRN'  Discharge Medications: 1. heparin (porcine) 5,000 unit/mL Solution Sig: One (1) cc Injection TID (3 times a day).
4. lisinopril 20 mg Tablet Sig: One (1) Tablet PO once a day: hold for systolic blood pressure <110, hr <60.
Lantus 100 unit/mL Solution Sig: Twenty (20) units Subcutaneous at bedtime: monitor blood sugar prior to meals and bedtime.
11. diltiazem HCl 120 mg Tablet Sig: One (1) Tablet PO three times a day: hold for blood pressure <110, hr <60.
